2 withdrawn, 1 unknown. 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Withdrawn 2 |
| Not applicable | 1 | Unknown 1 |
Follow Copper Sulfate: new trials by email Literature Review of Copper Sulfate trials Research Report on Copper Sulfate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tralement Versus a Fixed-dose Trace Element Combination Product to Evaluate Manganese Safety Tralement, Fixed-dose trace element combination product of zinc, copper, and selenious acid - Manganese Safety in Adults | Phase 4 | Withdrawn | American Regent, Inc. | 2025-02-01 | 2025-02-12 | |
| Tralement vs. Fixed-dose Trace Element Combination Product in Patients >3 to 17 Years of Age Requiring Long-term PN Tralement, Fixed-dose trace element combination product of zinc, copper, and selenious acid - Manganese Safety in Pediatric Patients | Phase 4 | Withdrawn | American Regent, Inc. | 2024-08-01 | 2024-11-15 | |
| The Reduction in Glucose Stimulated Insulin Secretion Induced by Cytokines May be Prevented by Copper Addition - Studies in Diabetic Patients copper sulfate - Hyperglycemia, Diabetes | Not applicable | Unknown | Hadassah Medical Organization | 100 | 2009-09-01 | 2009-02-18 |
Diabetes Mellitus (1) · Hyperglycemia (1)
American Regent, Inc. (2) · Hadassah Medical Organization (1)
Israel (1)
Itamar Raz, Prof (1) · Khaled Khechen, MD (1) · Mark Falone, MD (1)